Regulation of the renal NaCl cotransporter and its role in potassium homeostasis

EJ Hoorn, M Gritter, CA Cuevas… - Physiological …, 2020 - journals.physiology.org
Daily dietary potassium (K+) intake may be as large as the extracellular K+ pool. To avoid
acute hyperkalemia, rapid removal of K+ from the extracellular space is essential. This is …

Actinidia deliciosa (Kiwi fruit): A comprehensive review on the nutritional composition, health benefits, traditional utilization, and commercialization

D Satpal, J Kaur, V Bhadariya… - Journal of Food …, 2021 - Wiley Online Library
Kiwi fruit (Actinidia deliciosa) belongs to the family Actinidiaceae and genus Actinidia. It is
one of the most commercialized fruits on the international front and is loaded with many …

[HTML][HTML] Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) …

CM Clase, JJ Carrero, DH Ellison, ME Grams… - Kidney international, 2020 - Elsevier
Potassium disorders are common in patients with kidney disease, particularly in patients
with tubular disorders and low glomerular filtration rate. A multidisciplinary group of …

Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the …

B Pitt, SD Anker, DA Bushinsky… - European heart …, 2011 - academic.oup.com
Aims To evaluate efficacy and safety of RLY5016 (a non-absorbed, orally administered,
potassium [K+]-binding polymer) on serum K+ levels in patients with chronic heart failure …

Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on RAAS inhibitors

B Pitt, GL Bakris, DA Bushinsky, D Garza… - European journal of …, 2015 - Wiley Online Library
Aims We evaluated the effects of patiromer, a potassium (K+)‐binding polymer, in a pre‐
specified analysis of hyperkalaemic patients with heart failure (HF) in the OPAL‐HK trial …

Hyperkalemia in heart failure

CMS Sarwar, L Papadimitriou, B Pitt, I Piña… - Journal of the American …, 2016 - jacc.org
Disorders of potassium homeostasis can potentiate the already elevated risk of arrhythmia in
heart failure. Heart failure patients have a high prevalence of chronic kidney disease, which …

New insights into dietary approaches to potassium management in chronic kidney disease

K Sumida, A Biruete, BM Kistler, BH Khor… - Journal of Renal …, 2023 - Elsevier
Potassium disorders are one of the most common electrolyte abnormalities in patients with
chronic kidney disease (CKD), contributing to poor clinical outcomes. Maintaining serum …

Dietary reference values for potassium

EFSA Panel on Dietetic Products, Nutrition and … - EFSA …, 2016 - Wiley Online Library
Following a request from the European Commission, the EFSA Panel on Dietetic Products,
Nutrition and Allergies (NDA) derives dietary reference values (DRV s) for potassium. The …

Mechanism of action and pharmacology of patiromer, a nonabsorbed cross-linked polymer that lowers serum potassium concentration in patients with hyperkalemia

L Li, SD Harrison, MJ Cope, C Park… - Journal of …, 2016 - journals.sagepub.com
Hyperkalemia is a potentially life-threatening condition, and patients who have chronic
kidney disease, who are diabetic, or who are taking renin–angiotensin–aldosterone system …

Rationale and design of a randomized placebo-controlled clinical trial assessing the renoprotective effects of potassium supplementation in chronic kidney disease

M Gritter, L Vogt, SMH Yeung, RD Wouda… - Nephron, 2018 - karger.com
Abstract Background/Aims: Dietary potassium (K+) has beneficial effects on blood pressure
and cardiovascular (CV) outcomes. Recently, several epidemiological studies have …